You are here: Industry Insights > Sale

News List

Takeda Completes Sale of Xiidra® to Novartis americanpharmaceuticalreview
July 03, 2019
Takeda announced the completion of its sale of its Xiidra® (lifitegrast ophthalmic solution) 5% product to Novartis for $3.4 billion upfront in cash and up to an additional $1.9 billion in potential milestone payments.
GSK reported to have started the sale of $1.2 billion consumer health drugs europeanpharmaceuticalreview
June 27, 2019
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.
Taxing Sweetened Beverages Reduces Volume Sold drugs
May 15, 2019
Taxing Sweetened Beverages Reduces Volume Sold.
Sun Pharma posts net profit of ₹ 996 crores at Q2FY19 expressbpd
November 15, 2018
In H1FY19,the company’s sales / income from operations was at ₹ 13,985 crores
Madras HC stays online sale of medicines expressbpd
November 01, 2018
The court directed the Centre to file a counter and posted the matter for further hearing to November 9
Shire completes sale of oncology franchise biospectrumasia
September 05, 2018
International study develops innovative method to discover new anti-epileptic drug in record time, with potential to do the same for other diseases.
Shire completes sale of oncology franchise worldpharmanews
September 03, 2018
Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that it has completed the sale of its Oncology franchise to Servier S.A.S. for $2.4 billion.
Rare disease specialist Spectrum eyes potential $2B-plus sale: Bloomberg fiercepharma
June 29, 2018
Biopharma M&A has picked up this year with deals dominated by rare diseases and cancer, more than $34 billion all told, not counting Takeda's hefty $62 billion offer for Shire.
Cutting costs and Copaxone prices pays off for Teva, sending shares skyward fiercepharma
May 04, 2018
You could say Teva investors are pleasantly surprised. The embattled drugmaker's shares soared 8% in premarket trading Thursday after it unexpectedly raised guidance for the year...